Robert S Attiyeh - Director, Myriad Genetics Inc

As of November 17, 2008


Robert S Attiyeh Net Worth

  • Net worth is estimated to be at least $139.65K
  • Owns at least 3,000 units of Myriad Genetics Inc stock

Robert S Attiyeh Trading

  • Largest purchase of shares was 2,000 units , worth over $33.3K on February 6, 2004
  • In total has made about 7 transactions over 5 years
  • Usually trades in November, with the busiest year in 2006 and 2004
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Myriad Genetics Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Paul J. Diaz 2020 Transition Period $382,663 $8,394,628 $5,500,006 $682,000 $541,524 $15,500,821
R. Bryan Riggsbee 2020 Transition Period $265,454 $1,264,541 - $281,174 $5,237 $1,816,406
R. Bryan Riggsbee 2020 $552,796 $3,461,500 - $180,209 $8,836 $4,203,341
R. Bryan Riggsbee 2019 $466,650 $2,392,500 - $260,671 $19,162 $3,138,983
R. Bryan Riggsbee 2018 $432,000 $1,954,200 - $254,016 $5,366 $2,645,582
Jerry S. Lanchbury, Ph.D. 2020 Transition Period $256,618 $1,102,569 - $176,253 $5,827 $1,541,267
Jerry S. Lanchbury, Ph.D. 2020 $493,496 $1,197,200 - $131,599 $6,943 $1,829,238
Jerry S. Lanchbury, Ph.D. 2019 $508,595 $1,914,000 - $250,228 $12,927 $2,685,750
Jerry S. Lanchbury, Ph.D. 2018 $493,782 $1,628,500 - $244,422 $10,972 $2,377,676
Nicole Lambert 2020 Transition Period $217,726 $1,243,641 - $194,472 $5,542 $1,661,381
Nicole Lambert 2020 $386,859 $1,197,200 - $99,934 $20,713 $1,704,706
Mark Verratti 2020 Transition Period $204,651 $879,288 - $143,273 $8,123 $1,235,335
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899923/000089992321000031/a2021proxystatement.htm

Myriad Genetics Inc Insider Trading

  • The most recent transaction was 67,446 units sold on September 21, 2021 by Jayne B Hart worth over $2.27M
  • In the last 17 years, insiders at Myriad Genetics Inc sold an estimated value of $317.14M and bought an estimated value of $125.92M
  • The most active traders are Jerry S Lanchbury, Chief Scientific Officer,  Richard Marsh, E.V.P.,  and Peter D Meldrum, President & C.E.O.
  • Insider trading is most common in September, with the busiest year in 2007

MYRIAD GENETICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1